title: Influence of different biomaterials on the viability of Aggregatibacter actinomycetemcomitans.
abstract: OBJECTIVE
  The aim of the present in vitro study was to evaluate the effects of different biomaterials used for regenerative periodontal surgery on the growth of the periodontopathogen Aggregatibacter actinomycetemcomitans.
  
  
  METHODS
  Three commercially available biomaterials of synthetic origin (hydroxyapatite/beta-tricalcium phosphate, nanostructured hydroxyapatite paste, oily calcium hydroxide suspension), a bovine-derived xenograft as well as an enamel matrix derivative (EMD) were added in different concentrations to calibrated suspensions of A. actinomycetemcomitans ATCC 43718/33384 (serotype b/c). Equal aliquots (0.1 ml) for the viability assay were taken after 5 min, 1h, 3h, 8h and 24h, plated on blood agar and incubated in an anaerobic environment for 48 h at 37°C. Viable cell counts were expressed as colony forming units (cfu)/0.1 ml.
  
  
  RESULTS
  The results demonstrated that none of the investigated biomaterials could inhibit the growth of A. actinomycetemcomitans serotype b. A marked growth reduction of A. actinomycetemcomitans serotype c was observed in the presence of oily calcium hydroxide suspension and nanostructured hydroxyapatite. In contrast, no significant growth inhibition could be observed in the presence of hydroxyapatite/beta-tricalcium phosphate, enamel matrix derivative and bovine-derived xenograft.
  
  
  CONCLUSIONS
  The results of the present study suggest that none of the investigated biomaterials possesses antimicrobial properties against A. actinomycetemcomitans serotype b. Therefore, the use of these biomaterials for regenerative procedures should be weighted critically in the presence of A. actinomycetemcomitans serotype b.
authors.affiliation: Department of Operative Dentistry and Periodontology, University Medical Center, Johannes Gutenberg-University, Augustusplatz 2, 55131 Mainz, Germany. Kasaj@gmx.de
authors.forename: Adrian
authors.initials: A
authors.lastname: Kasaj
authors.forename: Brita
authors.initials: B
authors.lastname: Willershausen
authors.forename: Rüdiger
authors.initials: R
authors.lastname: Junker
authors.forename: Angelika
authors.initials: A
authors.lastname: Callaway
authors.forename: Ulrike
authors.initials: U
authors.lastname: Krahn
authors.forename: Beate
authors.initials: B
authors.lastname: Kraft
authors.forename: Michael
authors.initials: M
authors.lastname: Pietsch
mesh_terms: D016976:Aggregatibacter actinomycetemcomitans / Q000187:drug effects*; D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology*; D001857:Bone Matrix / Q000502:physiology; D002126:Calcium Hydroxide / Q000494:pharmacology; D002130:Calcium Phosphates / Q000494:pharmacology; D002417:Cattle; D003746:Dental Enamel Proteins / Q000494:pharmacology; D017886:Durapatite / Q000494:pharmacology; D016018:Least-Squares Analysis; D016014:Linear Models; D008422:Materials Testing; D050296:Microbial Viability / Q000187:drug effects; D049329:Nanostructures; D044968:Regenerative Medicine / Q000379:methods
chemical_list: D001672:Biocompatible Materials; D002130:Calcium Phosphates; D003746:Dental Enamel Proteins; C485817:beta-tricalcium phosphate; C109069:enamel matrix proteins; D017886:Durapatite; D002126:Calcium Hydroxide